Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
Clinical trial NCT03136055 · COMPLETED
Trial details
- NCT number
- NCT03136055
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2021-10-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.